The Translational Genomics Research Institute has entered into a non-exclusive agreement with Santa Clara, Calif.-based Affymetrix Inc. Under the agreement, TGen will use Affymetrix GeneChip analysis technology, known as Mapping 10K, to offer genotyping services to its collaborators.

According to the Business Journal, TGen already uses the Affymetrix platform to run core facility programs for the National Institutes of Mental Health and the National Institutes of Neurological Disease and Stroke. As part of the agreement, these programs have been expanded to run the Affymetrix DNA analysis technologies.

Affymetrix Chief Commercial Officer Trevor J. Nicholls told the Journal that the partnership will allow scientists to accelerate research into complex diseases.

"The flexibility and affordability of the Mapping 10K will allow TGen to provide both large research institutions and individual researchers with the most powerful genotyping technology available today," he said.

---

For more information:

"TGen, Affymetrix to team up on DNA analysis," Business Journal, 02/12/2004